Verfahren und Vorrichtung zur Freisetzung von Augenimplantaten
Anmelder: ALLERGAN, INC. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4732814
- Anmeldetag
- 7. Juli 2022
- Veröffentlichung
- 29. April 2026
- Rechtsraum
- EP
- IPC
- A61F9/00(ALLERGAN INC et al.)(TROGDEN JOHN T et al.)(DE JUAN JR EUGENE et al.)(WEBER DAVID et al.)
Abstract
A system for treating an eye of a patient in need including a delivery device having a housing sized to be held by an operator, an actuator and a distal nose cone; a needle coupled to and extending distal from the nose cone, the needle having a lumen and a beveled distal end defining a distal opening having a sharpened tip and heel proximal the distal opening; and a retention plug positioned within and spanning the lumen of the needle proximal to the heel; and an intraocular implant positioned within the lumen of the needle proximal to the retention plug. The retention plug is formed from a flowable retainer solution of hydroxypropyl methylcellulose (HPMC) in water having a concentration that is greater than 2.5% w:w and less than about 4% w:w. Related devices and methods are provided.
Anmelder
- Firma
- ALLERGAN, INC.
- Land
- 🇺🇸 USA
US-amerikanisches Pharmaunternehmen, bekannt für Botox und Produkte der Augenheilkunde. Seit 2020 Teil von AbbVie.
1.430 Patente in unserer Datenbank
Fachgebiete
Vertreten von
-
Hoffmann Eitle
Hoffmann Eitle · München